Effect of Helicobacter pylori Lipopolysaccharides on Human Polymorphonuclear Neutrophils and Endothelial Cells

[1]  G. Friedman,et al.  Helicobacter pylori infection and the risk of gastric carcinoma. , 1991, The New England journal of medicine.

[2]  J. Crabtree,et al.  Mucosal tumour necrosis factor alpha and interleukin-6 in patients with Helicobacter pylori associated gastritis. , 1991, Gut.

[3]  C. Galanos,et al.  Induction of human granulocyte chemiluminescence by bacterial lipopolysaccharides , 1987, Infection and immunity.

[4]  M. Blaser,et al.  Surface proteins from Helicobacter pylori exhibit chemotactic activity for human leukocytes and are present in gastric mucosa , 1992, The Journal of experimental medicine.

[5]  E. Isogai,et al.  Role of platelet-activating-factor (PAF) on cellular responses after stimulation with leptospire lipopolysaccharide. , 1997, Microbiology and immunology.

[6]  A. Moran,et al.  Activity in the Limulus amebocyte lysate assay and induction of tumor necrosis factor-α by diverse Helicobacter pylori lipopolysaccharide preparations , 1995 .

[7]  M. Hayashi,et al.  In vivo induction of apoptosis and immune responses in mice by administration of lipopolysaccharide from Porphyromonas gingivalis , 1996, Infection and immunity.

[8]  S. Ichiyama,et al.  Interleukin-8 activity correlates with histological severity in Helicobacter pylori-associated antral gastritis. , 1996, The American journal of gastroenterology.

[9]  S. Birkholz,et al.  Immunological activity of lipopolysaccharide of Helicobacter pylori on human peripheral mononuclear blood cells in comparison to lipopolysaccharides of other intestinal bacteria. , 1993, FEMS immunology and medical microbiology.

[10]  J. Primrose,et al.  Interleukin-8 expression in Helicobacter pylori infected, normal, and neoplastic gastroduodenal mucosa. , 1994, Journal of clinical pathology.

[11]  B. Marshall,et al.  UNIDENTIFIED CURVED BACILLI ON GASTRIC EPITHELIUM IN ACTIVE CHRONIC GASTRITIS , 1983, The Lancet.

[12]  D. Graham I. Helicobacter pylori: Its epidemiology and its role in duodenal ulcer disease , 1991, Journal of gastroenterology and hepatology.

[13]  K. Amano,et al.  Low antigenicity of the polysaccharide region of Helicobacter pylori lipopolysaccharides derived from tumors of patients with gastric cancer , 1997, Infection and immunity.

[14]  G. Rieder,et al.  Role of adherence in interleukin-8 induction in Helicobacter pylori-associated gastritis , 1997, Infection and immunity.

[15]  I. Helander,et al.  Low biological activity of Helicobacter pylori lipopolysaccharide , 1992, Infection and immunity.

[16]  T. Yokochi,et al.  Human Antibody Response to Helicobacter pylori Lipopolysaccharide: Presence of an Immunodominant Epitope in the Polysaccharide Chain of Lipopolysaccharide , 1998, Infection and Immunity.

[17]  J. Williams,et al.  Chemical and immunological characterization of lipopolysaccharides from phase I and phase II Coxiella burnetii , 1984, Journal of bacteriology.

[18]  R. Hatz,et al.  Stomach immunology and helicobacter pylori infection , 1992 .

[19]  A. Aruffo,et al.  Helicobacter pylori and Porphyromonas gingivalis lipopolysaccharides are poorly transferred to recombinant soluble CD14 , 1996, Infection and immunity.

[20]  T. Ogawa Chemical structure of lipid A from porphyromonas (bacteroides) gingivalis lipopolysaccharide , 1993, FEBS letters.

[21]  T. Kubota,et al.  Reactivities of Lewis antigen monoclonal antibodies with the lipopolysaccharides of Helicobacter pylori strains isolated from patients with gastroduodenal diseases in Japan , 1997, Clinical and diagnostic laboratory immunology.

[22]  M. Wilson,et al.  Serum-dependent and -independent effects of bacterial lipopolysaccharides on human neutrophil oxidative capacity in vitro. , 1982, Journal of the Reticuloendothelial Society.

[23]  B. Marshall,et al.  UNIDENTIFIED CURVED BACILLI IN THE STOMACH OF PATIENTS WITH GASTRITIS AND PEPTIC ULCERATION , 1984, The Lancet.

[24]  P. O’Toole,et al.  Stimulation of interleukin-8 production in epithelial cell lines by Helicobacter pylori , 1995, Infection and immunity.

[25]  B. Lindner,et al.  Structural characterization of the lipid A component of Helicobacter pylori rough- and smooth-form lipopolysaccharides , 1997, Journal of bacteriology.

[26]  M. Blaser,et al.  Activation of human THP-1 cells and rat bone marrow-derived macrophages by Helicobacter pylori lipopolysaccharide , 1995, Infection and immunity.